[Psychopharmacotherapy of mental disorders in hematological patients: security concerns].

D E Vybornykh S V Ivanov E G Gemdzhian Tatiana V Gaponova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)

Most psychotropic drugs are effective in relation to psychopathological disorders that develop in hematological patients and are safe when used at minimum/average therapeutic doses within the daily dosage ranges established by the official instructions for use.

Keyphrases

newly diagnosed
ejection fraction
end stage renal disease
prognostic factors
physical activity
patient reported outcomes